Correlation Between Phio Pharmaceuticals and CureVac NV

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Phio Pharmaceuticals and CureVac NV at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Phio Pharmaceuticals and CureVac NV into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Phio Pharmaceuticals Corp and CureVac NV, you can compare the effects of market volatilities on Phio Pharmaceuticals and CureVac NV and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Phio Pharmaceuticals with a short position of CureVac NV. Check out your portfolio center. Please also check ongoing floating volatility patterns of Phio Pharmaceuticals and CureVac NV.

Diversification Opportunities for Phio Pharmaceuticals and CureVac NV

0.58
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Phio and CureVac is 0.58. Overlapping area represents the amount of risk that can be diversified away by holding Phio Pharmaceuticals Corp and CureVac NV in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CureVac NV and Phio Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Phio Pharmaceuticals Corp are associated (or correlated) with CureVac NV. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CureVac NV has no effect on the direction of Phio Pharmaceuticals i.e., Phio Pharmaceuticals and CureVac NV go up and down completely randomly.

Pair Corralation between Phio Pharmaceuticals and CureVac NV

Given the investment horizon of 90 days Phio Pharmaceuticals Corp is expected to under-perform the CureVac NV. In addition to that, Phio Pharmaceuticals is 1.96 times more volatile than CureVac NV. It trades about -0.08 of its total potential returns per unit of risk. CureVac NV is currently generating about -0.07 per unit of volatility. If you would invest  270.00  in CureVac NV on August 24, 2024 and sell it today you would lose (14.00) from holding CureVac NV or give up 5.19% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Phio Pharmaceuticals Corp  vs.  CureVac NV

 Performance 
       Timeline  
Phio Pharmaceuticals Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Phio Pharmaceuticals Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's forward indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.
CureVac NV 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days CureVac NV has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in December 2024. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Phio Pharmaceuticals and CureVac NV Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Phio Pharmaceuticals and CureVac NV

The main advantage of trading using opposite Phio Pharmaceuticals and CureVac NV positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Phio Pharmaceuticals position performs unexpectedly, CureVac NV can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CureVac NV will offset losses from the drop in CureVac NV's long position.
The idea behind Phio Pharmaceuticals Corp and CureVac NV pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Other Complementary Tools

Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites